Re-appointment of Director and Statutory Auditor approved at AGM

Management Changes View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+4.8%Reaction day

₹76.20

prior close

₹75.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.0%+4.8% vs market

Pharmaceuticals peers, median of 173sector-0.7%+5.5% vs sector

On the reaction day the stock moved 4.8 pts more than Nifty Microcap 250 and 5.5 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.0

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+4.8+0.0+4.8-0.7+5.5

Next day

+5.0+1.3+3.7+0.6+4.4

+7.6+1.1+6.5+0.3+7.3

-0.1-1.7+1.7-2.3+2.3

-0.3-1.4+1.2-2.1+1.9

—-0.6—-2.5—

—+0.3—-2.5—

15d

-7.4-6.1-1.3-4.3-3.2

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

At the 33rd AGM on Sept 30, 2026, members approved the re-appointment of Mrs. Abha Agrawal as Non-Executive Non-Independent Director post attaining age 75. She is a promoter, spouse of Managing Director Jagdish Agrawal, and has 30 plus years of experience in chemicals and electrical switches. Also re-appointed M/s. Jaimin Shah and Associates as Statutory Auditor for 1 year till the next AGM.

Likely market impact

Routine AGM re-appointments of existing director and auditor. No material change for shareholders expected.